Description
GLYSIT 5 mg Film-Coated Tablets – 28’s
GLYSIT 5 mg Tablets contain Empagliflozin, a selective SGLT2 (Sodium-Glucose Co-Transporter 2) inhibitor indicated for the treatment of type 2 diabetes mellitus. Empagliflozin helps lower blood sugar levels by blocking the reabsorption of glucose in the kidneys, promoting its excretion through urine, and thus improving glycemic control independently of insulin action.
This 5 mg dosage is often used as a starting dose or for patients requiring a lower-strength formulation based on their medical profile, renal function, or as part of combination therapy. In addition to its glucose-lowering effect, Empagliflozin offers cardiovascular and renal protective benefits, particularly in patients with a history of heart failure or chronic kidney disease.
GLYSIT is typically taken once daily and can be used alone or in combination with other antidiabetic medications.
Key Features:
-
Contains 5 mg of Empagliflozin per film-coated tablet
-
SGLT2 inhibitor that lowers blood sugar via urinary glucose excretion
-
May support weight loss and reduce blood pressure
-
Offers cardiovascular and renal protection in eligible patients
-
Suitable for monotherapy or combination treatment
-
28 tablets per pack – one-month supply for once-daily dosing
Usage:
Take as prescribed by your healthcare provider. Adequate hydration and regular monitoring of renal function are recommended during therapy.
Reviews
There are no reviews yet.